1Schulze, MB, Schulz, M, Heidemann, C, Schienkiewitz, A, Hoffmann, K & Boeing, H (2007) Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 167, 956–965.
2de Munter, JS, Hu, FB, Spiegelman, D, Franz, M & van Dam, RM (2007) Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 4, e261.
3Cauchi, S, El Achhab, Y, Choquet, H, et al. (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85, 777–782.
4Florez, JC (2007) The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care 10, 391–396.
5Weedon, MN (2007) The importance of TCF7L2. Diabet Med 24, 1062–1066.
6Boeing, H, Korfmann, A & Bergmann, MM (1999) Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43, 205–215.
7Bergmann, MM, Bussas, U & Boeing, H (1999) Follow-up procedures in EPIC-Germany – data quality aspects. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 43, 225–234.
8Bohlscheid-Thomas, S, Hoting, I, Boeing, H & Wahrendorf, J (1997) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26, Suppl. 1, S59–S70.
9Kroke, A, Klipstein-Grobusch, K, Voss, S, Moseneder, J, Thielecke, F, Noack, R & Boeing, H (1999) Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24 h dietary recall methods. Am J Clin Nutr 70, 439–447.
10Hampe, J, Wollstein, A, Lu, T, Frevel, HJ, Will, M, Manaster, C & Schreiber, S (2001) An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics 17, 654–655.
11Barlow, WE, Ichikawa, L, Rosner, D & Izumi, S (1999) Analysis of case–cohort designs. J Clin Epidemiol 52, 1165–1172.
12Florez, JC, Jablonski, KA, Bayley, N, Pollin, TI, de Bakker, PI, Shuldiner, AR, Knowler, WC, Nathan, DM & Altshuler, D (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355, 241–250.
13Hagander, B, Schersten, B, Asp, NG, Sartor, G, Agardh, CD, Schrezenmeir, J, Kasper, H, Ahren, B & Lundquist, I (1984) Effect of dietary fibre on blood glucose, plasma immunoreactive insulin, C-peptide and GIP responses in non insulin dependent (type 2) diabetics and controls. Acta Med Scand 215, 205–213.
14Juntunen, KS, Niskanen, LK, Liukkonen, KH, Poutanen, KS, Holst, JJ & Mykkanen, HM (2002) Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects. Am J Clin Nutr 75, 254–262.
15Schäfer, SA, Tschritter, O, Machicao, F, et al. (2007) Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50, 2443–2450.
16Shu, L, Sauter, NS, Schulthess, FT, Matveyenko, AV, Oberholzer, J & Maedler, K (2008) TCF7L2 regulates cell survival and function in human pancreatic islets. Diabetes 57, 645–653.